Increased Expression of Platelet-Derived Growth Factor A and Insulin-Like Growth Factor-I in BAL Cells During the Development of Bleomycin-lnduced Pulmonary Fibrosis in Mice

¹ From the Second Department of Internal Medicine, Hiroshima (Japan) University School of Medicine

Current concepts suggest that macrophages may play a central role in pulmonary fibrosis by virtue of their ability to release a variety of cytokines. In this study, the expression of interleukin (IL)-1 and β, platelet-derived growth factor (PDGF) A and B, and insulinlike growth factor (IGF) I in BAL cells, which may be involved in fibroblast proliferation, was investigated in murine bleomycin (BLM)-induced pulmonary fibrosis. BAL cells were obtained at 1, 15, and 29 days from Institute for Cancer Research mice after 10 days of intraperitoneal administration of BLM. The relative amounts of cytokine messenger RNA (mRNA) were evaluated by the reverse transcription-polymerase chain reaction method, which simultaneously amplified complementary DNA for cytokines and β-actin as an internal control. The level of IL-1β mRNA in BLM-treated mice was increased 4.5-fold compared with that in saline solution-treated (control) mice 1 day after treatment, while no significant differences were observed between the two groups at 15 and 29 days. The mRNAs of PDGF-A and IGF-I in BLM-treated mice were sustained at levels eightfold and threefold to fourfold, respectively, those of controls over 4 weeks. No significant differences were noted in IL-1 and PDGF-B expression between the two groups. We conclude that IL-1β released from macrophages may be important in the early phase of inflammatory responses and that PDGF-A and IGF-I may play important roles in the development of BLM-induced pulmonary fibrosis.

Key Words: bleomycin • bronchoalveolar lavage (BAL) • insulin-like growth factor (IGF)-I • mouse • platelet-derived growth factor (PDGF) • pulmonary fibrosis • reverse transcription-polymerase chain reaction (RT-PCR)

Submitted on July 11, 1995
Accepted on September 11, 2007

This article has been cited by other articles:

				L. M. Schnapp, S. Donohoe, J. Chen, D. A. Sunde, P. M. Kelly, J. Ruzinski, T. Martin, and D. R. Goodlett Mining the Acute Respiratory Distress Syndrome Proteome: Identification of the Insulin-Like Growth Factor (IGF)/IGF-Binding Protein-3 Pathway in Acute Lung Injury Am. J. Pathol., July 1, 2006; 169(1): 86 - 95. [Abstract] [Full Text] [PDF]

				C. Agostini and C. Gurrieri Chemokine/Cytokine cocktail in idiopathic pulmonary fibrosis. Proceedings of the ATS, January 1, 2006; 3(4): 357 - 363. [Abstract] [Full Text] [PDF]

				Y. Aono, Y. Nishioka, M. Inayama, M. Ugai, J. Kishi, H. Uehara, K. Izumi, and S. Sone Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1279 - 1285. [Abstract] [Full Text] [PDF]

				C. A. Feghali-Bostwick IGF-I: mediator of fibrosis or carcinogenesis? Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L803 - L804. [Full Text] [PDF]

				S. K. Frankel, B. M. Moats-Staats, C. D. Cool, M. W. Wynes, A. D. Stiles, and D. W. H. Riches Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L805 - L812. [Abstract] [Full Text] [PDF]

				A. Abdollahi, M. Li, G. Ping, C. Plathow, S. Domhan, F. Kiessling, L. B. Lee, G. McMahon, H.-J. Grone, K. E. Lipson, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis J. Exp. Med., March 21, 2005; 201(6): 925 - 935. [Abstract] [Full Text] [PDF]

				S. Murakami, N. Nagaya, T. Itoh, T. Fujii, T. Iwase, K. Hamada, H. Kimura, and K. Kangawa C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1172 - L1177. [Abstract] [Full Text] [PDF]

				M. W. Wynes, S. K. Frankel, and D. W. H. Riches IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal J. Leukoc. Biol., November 1, 2004; 76(5): 1019 - 1027. [Abstract] [Full Text] [PDF]

				Y. Zhuo, J. Zhang, M. Laboy, and J. A. Lasky Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L182 - L188. [Abstract] [Full Text] [PDF]

				W A Dik, R J McAnulty, M A Versnel, B A E Naber, L J I Zimmermann, G J Laurent, and S E Mutsaers Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats Thorax, September 1, 2003; 58(9): 765 - 771. [Abstract] [Full Text] [PDF]

				P. M. Krein, P. J. B. Sabatini, W. Tinmouth, F. H. Y. Green, and B. W. Winston Localization of Insulin-like Growth Factor-I in Lung Tissues of Patients with Fibroproliferative Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 83 - 90. [Abstract] [Full Text] [PDF]

				G. Izbicki, R. Or, T. G. Christensen, M. J. Segel, A. Fine, R. H. Goldstein, and R. Breuer Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1110 - L1116. [Abstract] [Full Text] [PDF]

				S. Ogata, N. Yorioka, and N. Kohno Glucose and Prednisolone Alter Basic Fibroblast Growth Factor Expression in Peritoneal Mesothelial Cells and Fibroblasts J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2787 - 2796. [Abstract] [Full Text] [PDF]

				C. A. BLOOR, R. A. KNIGHT, R. K. KEDIA, M. A. SPITERI, and J. T. ALLEN Differential mRNA Expression of Insulin-like Growth Factor-1 Splice Variants in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 265 - 272. [Abstract] [Full Text] [PDF]

				X. Y. ZHANG, S. SHIMURA, T. MASUDA, H. SAITOH, and K. SHIRATO Antisense Oligonucleotides to NF-kappa B Improve Survival in Bleomycin-induced Pneumopathy of the Mouse Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1561 - 1568. [Abstract] [Full Text] [PDF]

				T. Yehualaeshet, R. O'Connor, A. Begleiter, J. E. Murphy-Ullrich, R. Silverstein, and N. Khalil A CD36 Synthetic Peptide Inhibits Bleomycin-Induced Pulmonary Inflammation and Connective Tissue Synthesis in the Rat Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 204 - 212. [Abstract] [Full Text]

				J.-M. CHARPIN, M. STERN, D. GRENET, and D. ISRAËL-BIET Insulinlike Growth Factor-1 in Lung Transplants with Obliterative Bronchiolitis Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1991 - 1998. [Abstract] [Full Text]

				K. TAMAGAWA, Y. TAOOKA, A. MAEDA, K. HIYAMA, S. ISHIOKA, and M. YAMAKIDO Inhibitory Effects of a Lecithinized Superoxide Dismutase on Bleomycin-Induced Pulmonary Fibrosis in Mice Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1279 - 1284. [Abstract] [Full Text]

				M. Fujiki, T. Shinbori, M. Suga, H. Miyakawa, and M. Ando Role of T Cells in Bronchoalveolar Space in the Development of Interstitial Pneumonia Induced by Superantigen in Autoimmune-Prone Mice Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 675 - 683. [Abstract] [Full Text]

				G. Gurujeyalakshmi, M. A. Hollinger, and S. N. Giri Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L311 - L318. [Abstract] [Full Text] [PDF]

				S.-T. UH, Y. INOUE, T. E. KING Jr., E. D. CHAN, L. S. NEWMAN, and D. W. H. RICHES Morphometric Analysis of Insulin-like Growth Factor-I Localization in Lung Tissues of Patients with Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1626 - 1635. [Abstract] [Full Text] [PDF]

				Y. TAOOKA, A. MAEDA, K. HIYAMA, S. ISHIOKA, and M. YAMAKIDO Effects of Neutrophil Elastase Inhibitor on Bleomycin-Induced Pulmonary Fibrosis in Mice Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 260 - 265. [Abstract] [Full Text]